Left ventricular pressure-volume measurements and myocardial gene expression profile in type 2 diabetic Goto-Kakizaki rats

Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12.

Abstract

The Goto-Kakizaki (GK) rat, a non-obese model of type 2 diabetes mellitus (T2DM), was generated by the selective inbreeding of glucose-intolerant Wistar rats. This is a convenient model for studying diabetes-induced cardiomyopathy independently from the effects of the metabolic syndrome. We investigated the myocardial functional and structural changes and underlying molecular pathomechanisms of short-term and mild T2DM. The presence of DM was confirmed by an impaired oral glucose tolerance in the GK rats compared with the age-matched nondiabetic Wistar rats. Data from cardiac catheterization showed that in GK rats, although the systolic indexes were not altered, the diastolic stiffness was increased compared with nondiabetics (end-diastolic-pressure-volume-relationship: 0.12 ± 0.04 vs. 0.05 ± 0.01 mmHg/μl, P < 0.05). Additionally, DM was associated with left-ventricular hypertrophy and histological evidence of increased myocardial fibrosis. The plasma pro-B-type natriuretic peptide, the cardiac troponin-T, glucose, and the urinary glucose concentrations were significantly higher in GK rats. Among the 125 genes surveyed using PCR arrays, DM significantly altered the expression of five genes [upregulation of natriuretic peptide precursor-A and connective tissue growth factor, downregulation of c-reactive protein, interleukin-1β, and tumor necrosis factor (TNF)-α mRNA-level]. Of the altered genes, which were evaluated by Western blot, only TNF-α protein expression was significantly decreased. The ECG recordings revealed no significant differences. In conclusion, while systolic dysfunction, myocardial inflammation, and abnormal electrical conduction remain absent, short-term and mild T2DM induce the alteration of cardiac TNF-α at both the mRNA and protein levels. Further assessments are required to reveal if TNF-α plays a role in the early stage of diabetic cardiomyopathy development.

Keywords: Goto-Kakizaki rats; cardiac function; diabetic cardiomyopathy; gene expression profiling; type 2 diabetes mellitus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / genetics
  • Atrial Natriuretic Factor / genetics
  • Blood Glucose / metabolism
  • C-Reactive Protein / genetics
  • Connective Tissue Growth Factor / genetics
  • Diabetes Mellitus, Type 2 / genetics*
  • Diabetes Mellitus, Type 2 / pathology
  • Diabetes Mellitus, Type 2 / physiopathology
  • Down-Regulation
  • Echocardiography
  • Electrocardiography
  • Fibrosis
  • Glucose Tolerance Test
  • Glycosuria
  • Hypertrophy, Left Ventricular / genetics*
  • Hypertrophy, Left Ventricular / pathology
  • Hypertrophy, Left Ventricular / physiopathology
  • Immunohistochemistry
  • In Situ Nick-End Labeling
  • Inflammation / genetics
  • Interleukin-1beta / genetics
  • Male
  • Myocardium / metabolism*
  • Myocardium / pathology
  • Natriuretic Peptide, Brain / metabolism
  • Oxidative Stress / genetics
  • Peptide Fragments / metabolism
  • Polymerase Chain Reaction
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Wistar
  • Signal Transduction
  • Troponin T / metabolism
  • Tumor Necrosis Factor-alpha / genetics
  • Tyrosine / analogs & derivatives
  • Tyrosine / metabolism
  • Up-Regulation
  • Ventricular Dysfunction, Left / genetics*
  • Ventricular Dysfunction, Left / pathology
  • Ventricular Dysfunction, Left / physiopathology
  • Ventricular Function, Left*
  • Ventricular Pressure*

Substances

  • Blood Glucose
  • IL1B protein, rat
  • Interleukin-1beta
  • Peptide Fragments
  • RNA, Messenger
  • Troponin T
  • Tumor Necrosis Factor-alpha
  • atrial natriuretic peptide, rat
  • pro-brain natriuretic peptide (1-76)
  • Natriuretic Peptide, Brain
  • Connective Tissue Growth Factor
  • 3-nitrotyrosine
  • Tyrosine
  • Atrial Natriuretic Factor
  • C-Reactive Protein